MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia

Adrián González-López1, Alina Aguirre, Inés López-Alonso

  • 1Departamento de Biología Funcional, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain.

Plos One
|July 7, 2012
PubMed

Insights

Matrix metalloproteinase-8 (MMP-8) absence exacerbates lung inflammation during endotoxemia. MMP-8 deficiency increases alarmins S100A8/S100A9 and activates NF-κB, highlighting MMP-8

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Matrix metalloproteinase-8 (MMP-8) is a key regulator of inflammation, primarily released by neutrophils.
  • Its role in modulating inflammatory mediators and its specific involvement in endotoxemia models require further elucidation.

Purpose of the Study:

  • To investigate the role of MMP-8 in an experimental model of endotoxemia.
  • To identify downstream inflammatory mediators affected by MMP-8 deficiency.

Main Methods:

  • Endotoxemia was induced by intraperitoneal lipopolysaccharide (LPS) injection in wildtype and MMP-8 knockout mice.
  • Lung inflammatory response, neutrophilic infiltration, and protein levels of alarmins (S100A8, S100A9) and chemokines (MIP-1α, MIP-2, LIX) were analyzed.
  • Proteomic approaches and Western blotting were employed to assess molecular differences.

Main Results:

  • Mice lacking MMP-8 exhibited a heightened lung inflammatory response and increased neutrophilic infiltration following LPS administration.
  • Proteomic analysis revealed significantly elevated levels of S100A8 and S100A9 alarmins in the lungs of MMP-8 deficient mice.
  • Elevated MIP-1α levels and activation of the non-canonical NF-κB pathway were observed in MMP-8 knockout mice, without changes in CXC-chemokines.

Conclusions:

  • MMP-8 plays a crucial role in modulating the levels of S100A8 and S100A9.
  • The absence of MMP-8 potentiates the lung inflammatory response during endotoxemia, partly through increased alarmin expression and NF-κB activation.